SEC Form 4 · accession 0001636050-16-000044
Axovant Sciences Ltd. · AXON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary P. Pisano
Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 6:35 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636050
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.99 | Jun 15, 2016 | A | 94,000 | A | — | Jun 15, 2026 | Common Shares | 94,000 | 94,000 | D |
Explanation of responses
- F1This option vests over a period of three years, with one third of the common shares underlying the option vesting on each of the first, second and third anniversaries of the June 15, 2016 date of grant. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.